# JNJ-2113

Type: Technology

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/jnj-2113-technology
Canonical HTML page: https://getbiobrief.com/entity/jnj-2113-technology

## Recent coverage (1 stories)

### Protagonist Therapeutics Surges 120% as Major Fund Trims $170M Stake
2026-02-25 21:44:08 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

Protagonist Therapeutics has seen its share price skyrocket by 120% following significant clinical and regulatory milestones, yet a major institutional investor has disclosed a $170 million exit. This divergence highlights a classic 'sell the news' moment or strategic rebalancing amidst a period of high valuation for the peptide-based drug developer.
Full story: https://getbiobrief.com/story/protagonist-therapeutics-stock-surge-institutional-exit

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.